Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 12;39(5):56.
doi: 10.1007/s12032-022-01666-3.

Management of oligoprogression in non-small cell lung cancer patients

Alfredo Tartarone  1 , Rosa Lerose  2 , Marina Tartarone  3
Affiliations
Review

Management of oligoprogression in non-small cell lung cancer patients

Alfredo Tartarone et al. Med Oncol. .

Abstract

Oligoprogression is an emerging concept in oncology representing a state where after an initially successfully local or systemic treatment a disease progression occurs characterized by the appearance of a single or few new lesions. We reviewed the literature and explained the rationale of the therapeutic choices by referring to the current guidelines and literature data. In any case, the treatment of oligometastatic disease should be tailored to suit the individual patient with the aim of maximizing the benefit of each line of therapy.

Keywords: Non-small cell lung cancer; Oligometastatic disease; Oligoprogression.

PubMed Disclaimer

References

    1. Planchard D, Popat S, Kerr K, et al. Metastatic non small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Updated version 15 September 2020. Ann Oncol. 2020;29:iv192–237. - DOI
    1. Lievens Y, Guckenberger M, Gomez D, et al. Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document. Radiother Oncol. 2020;148:157–66. - DOI
    1. Dingemans AC, Hendriks LEL, Berghmans T, et al. Definition of synchronous oligometastatic non small cell lung cancer-a consensus report. J Thorac Oncol. 2019;14:2109–19. - DOI
    1. Amini A, Verma V, Simone CB II, et al. American Radium Society appropriate use criteria on radiation therapy in oligometastatic or oligoprogressive non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2021;112:361–75. - DOI
    1. Uramoto H, Tanaka F. Recurrence after surgery in patients with NSCLC. Transl Lung Cancer Res. 2014;3:242–9. - PubMed - PMC

MeSH terms

LinkOut - more resources